Hiroyuki Yasuda

7PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2025
An organoid library unveils subtype-specific IGF-1 dependency via a YAP-AP1 axis in human small cell lung cancer.

Takahiro Fukushima, Kazuhiro Togasaki, Junko Hamamoto

|Sep 06, 2024
Therapeutic Efficacy of IL7/CCL19-Expressing CAR-T Cells in Intractable Solid Tumor Models of Glioblastoma and Pancreatic Cancer.

Keisuke Ohta, Yukimi Sakoda, Keishi Adachi

|Oct 14, 2021
Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model.

Kei Haga, Reiko Takai-Todaka, Yuta Matsumura

|Jun 04, 2021
Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.

Kota Ishioka, Hiroyuki Yasuda, Junko Hamamoto

|Oct 27, 2020
SHOC2 Is a Critical Modulator of Sensitivity to EGFR-TKIs in Non-Small Cell Lung Cancer Cells.

Hideki Terai, Junko Hamamoto, Katsura Emoto

Pageof 2